Group One Trading’s RAPTOR PHARMACEUTICAL CORP COM STK (DE) RPTP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | – | Sell |
-617,200
| Closed | -$5.54M | – | 5320 |
|
|
2016
Q3 | $5.54M | Buy |
617,200
+166,800
| +37% | +$1.19M | 0.06% | 376 |
|
|
2016
Q2 | $2.42M | Sell |
450,400
-8,700
| -2% | -$44.6K | 0.03% | 712 |
|
|
2016
Q1 | $2.11M | Sell |
459,100
-713,400
| -61% | -$2.87M | 0.03% | 740 |
|
|
2015
Q4 | $6.1M | Sell |
1,172,500
-383,000
| -25% | -$2.22M | 0.07% | 297 |
|
|
2015
Q3 | $9.41M | Sell |
1,555,500
-1,037,500
| -40% | -$12.7M | 0.13% | 164 |
|
|
2015
Q2 | $40.9M | Buy |
2,593,000
+590,200
| +29% | +$7.17M | 0.57% | 13 |
|
|
2015
Q1 | $21.8M | Buy |
2,002,800
+1,071,300
| +115% | +$10.9M | 0.34% | 35 |
|
|
2014
Q4 | $9.8M | Buy |
931,500
+259,400
| +39% | +$2.53M | 0.15% | 122 |
|
|
2014
Q3 | $6.45M | Sell |
672,100
-401,100
| -37% | -$4.1M | 0.1% | 216 |
|
|
2014
Q2 | $12.4M | Buy |
1,073,200
+120,700
| +13% | +$1.1M | 0.19% | 82 |
|
|
2014
Q1 | $9.53M | Buy |
952,500
+640,600
| +205% | +$9.25M | 0.16% | 110 |
|
|
2013
Q4 | $4.06M | Buy |
311,900
+277,700
| +812% | +$3.82M | 0.06% | 323 |
|
|
2013
Q3 | $511K | Sell |
34,200
-9,400
| -22% | -$113K | 0.01% | 1589 |
|
|
2013
Q2 | $408K | Buy |
+43,600
| New | +$295K | 0.01% | 1518 |
|
Group One Trading's RPTP Position: Q4 2016 in Review
Group One Trading sold out of RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) in Q4 2016, closing a stake of 160,615 shares — an estimated $1.44M sold.
Group One Trading first reported a position in RPTP in Q4 2013 and held it in 12 quarters. The position peaked at $20.8M in Q2 2015. 0 funds tracked by Wall St. Rank hold RPTP as of Q4 2016.
- Group One Trading reported no remaining RAPTOR PHARMACEUTICAL CORP COM STK (DE) position as of Q4 2016 after selling out during the quarter.
- Group One Trading sold 160,615 RAPTOR PHARMACEUTICAL CORP COM STK (DE) shares in Q4 2016, an estimated $1.44M.
- Group One Trading first reported a position in RAPTOR PHARMACEUTICAL CORP COM STK (DE) in Q4 2013 and held it in 12 quarters.
- Group One Trading's RAPTOR PHARMACEUTICAL CORP COM STK (DE) position peaked at $20.8M in Q2 2015.
- 0 funds tracked by Wall St. Rank held RAPTOR PHARMACEUTICAL CORP COM STK (DE) as of Q4 2016.
Based on Group One Trading's 13F filing for Q4 2016, filed 15 Feb 2017.